ACIU Operating Cycle from 2010 to 2026

ACIU Stock  USD 3.41  0.03  0.87%   
AC Immune Operating Cycle yearly trend continues to be comparatively stable with very little volatility. Operating Cycle will likely drop to 32.17 in 2026. From the period from 2010 to 2026, AC Immune Operating Cycle quarterly data regression had r-value of (0.60) and coefficient of variation of  99.75. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
33.86
Current Value
32.17
Quarterly Volatility
146.5792966
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 145.3 K or Selling General Administrative of 9.4 M, as well as many indicators such as Price To Sales Ratio of 9.77, Dividend Yield of 0.0 or PTB Ratio of 2.38. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
  
Build AI portfolio with ACIU Stock
Check out the analysis of AC Immune Correlation against competitors.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

Latest AC Immune's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of AC Immune over the last few years. It is AC Immune's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AC Immune's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

ACIU Operating Cycle Regression Statistics

Arithmetic Mean146.95
Geometric Mean74.61
Coefficient Of Variation99.75
Mean Deviation135.72
Median55.64
Standard Deviation146.58
Sample Variance21,485
Range379
R-Value(0.60)
Mean Square Error14,799
R-Squared0.35
Significance0.01
Slope(17.28)
Total Sum of Squares343,768

ACIU Operating Cycle History

2026 32.17
2025 33.86
2024 29.44
2023 371.04
2022 74.21
2021 -8.22
2020 25.85

About AC Immune Financial Statements

AC Immune shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although AC Immune investors may analyze each financial statement separately, they are all interrelated. The changes in AC Immune's assets and liabilities, for example, are also reflected in the revenues and expenses on on AC Immune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 33.86  32.17 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.